Zentalis Pharmaceuticals, Inc. (ZNTL) Financials

ZNTL Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 562.0 million 124.6 million
2023-09-30 585.7 million 103.8 million
2023-06-30 621.4 million 98.2 million
2023-03-31 489.3 million 103.7 million

ZNTL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -40.8 million 13.9 million
2023-09-30 -38.8 million 13.9 million
2023-06-30 -79.6 million 13.3 million
2023-03-31 -49.3 million 13.7 million

ZNTL Net Income

No data available :(

ZNTL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 482.9 million - 43.2 million
2023-09-30 516.6 million - 45.7 million
2023-06-30 553.0 million - 46.4 million
2023-03-31 392.5 million - 44.8 million

ZNTL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 70.8 million
2023-09-30 70.6 million
2023-06-30 60.8 million
2023-03-31 59.3 million

ZNTL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 173000 51.6 million 16.4 million 337001
2023-09-30 91000 46.8 million 16.0 million -
2023-06-30 319000 42.7 million 15.7 million -
2023-03-31 209000 48.6 million 16.4 million -

ZNTL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 337000
2023-09-30 - 348000
2023-06-30 - 344000
2023-03-31 - 360000

ZNTL

Price: $11.71

52 week price:
9.56
31.46

Earnings Per Share: -4.47 USD

P/E Ratio: -2.52

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 349136

Market Capitalization: 831.6 million

Links: